Senate Bill 499
Prescription drug cost reporting by manufacturers and providing a penalty
Stopped in committee
It never got a , so it never came up for a vote. To try again, a lawmaker would have to start a new bill.
-
Introduced, passed
Aug 5, 2021
-
Committee, stopped here
Stopped here. No public hearing was held.
-
Senate vote, not reached
-
Assembly vote, not reached
-
Governor, not reached
-
Law, not reached
Latest entry in the official record, Mar 15, 2022: “Failed to pass pursuant to ”
It never got a hearing in the Senate Committee on Health. See every bill that never got a hearing this session.
Following saves it on this device. New actions show on your Following page. You can also get updates in a feed reader.
Terms on this page
Committee
A small group of lawmakers that looks at a bill first. Most bills never leave committee.
Public hearing
A meeting where anyone can speak to a committee about a bill, or send written comments.
Senate Joint Resolution 1
The session's calendar. Any bill not passed by its last voting day dies.
Official term: Failed to pass pursuant to SJR 1. More in the glossary
Legislative Reference Bureau
The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.
Official term: LRB analysis. More in the glossary
Author
A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.
Official term: Author, coauthor. More in the glossary
Signed on in support
Lawmakers who back a bill without being one of its authors, often from the other chamber.
Official term: Cosponsor. More in the glossary
What it would have done
Summary by the , the Legislature's nonpartisan drafting office. It's their wording, not ours.
This bill requires certain cost reporting by manufacturers of brand-name and generic drugs. The bill requires a manufacturer to notify the Department of Health Services and the Office of the Commissioner of Insurance if it is 1) increasing the wholesale acquisition cost of a brand-name drug on the market in Wisconsin by more than 25 percent over a 24-month period; 2) intending to introduce in Wisconsin a brand-name drug that has an annual wholesale acquisition cost of $30,000 or more;
3) increasing the wholesale acquisition cost of a generic drug on the market in Wisconsin by more than 25 percent or by more than $300 during any 12-month period; or 4) intending to introduce in Wisconsin a generic drug that has an annual wholesale acquisition cost of $3,000 or more. The manufacturer must provide the notice at least 30 days before the planned date of the increase or introduction and must provide a justification including a description described in the bill. A manufacturer is also required to annually report to DHS and OCI the value of price concessions provided to each pharmacy benefit manager for each drug sold in Wisconsin for which a notice was required. The bill also requires each manufacturer of a brand-name or generic drug sold in Wisconsin to submit to DHS and OCI a report containing a description of each manufacturer-sponsored assistance program in effect during the previous year that includes the criteria for participation, the program terms, and the number of prescriptions and the total market value of assistance provided to residents of Wisconsin under the program. The manufacturer must certify the information provided in a notice or report required under the bill under penalty of perjury, and failure to provide the notice or report is subject to a forfeiture determined by DHS but not to exceed $10,000 per day past due.
Read the full summary Show less
The bill requires DHS to publish the pricing justification information reported by manufacturers on its Internet site. DHS must also analyze the information and publish a report on its Internet site describing trends in drug pricing.
Who's behind it
9 senators are its . All 9 are Democrats.
16 more lawmakers .
See all 25 names Hide the names
Authors (9)
- Melissa Agard · Democrat, Senate
- Tim Carpenter · Democrat, Senate
- Jon Erpenbach · Democrat, Senate
- LaTonya Johnson · Democrat, Senate
- Chris Larson · Democrat, Senate
- Brad Pfaff · Democrat, Senate
- Janis Ringhand · Democrat, Senate
- Jeff Smith · Democrat, Senate
- Bob Wirch · Democrat, Senate
Signed on in support (16)
- Deb Andraca · Democrat, Assembly
- David Bowen · Democrat, Assembly
- Rachael Cabral-Guevara · Republican, Senate
- Sue Conley · Democrat, Assembly
- Gary Hebl · Democrat, Assembly
- Greta Neubauer · Democrat, Assembly
- Sondy Pope · Democrat, Assembly
- Sara Rodriguez · Democrat, Assembly
- Katrina Shankland · Democrat, Assembly
- Kristina Shelton · Democrat, Assembly
- Christine Sinicki · Democrat, Assembly
- Lee Snodgrass · Democrat, Assembly
- Mark Spreitzer · Democrat, Senate
- Shelia Stubbs · Democrat, Assembly
- Robyn Vining · Democrat, Assembly
- Don Vruwink · Democrat, Assembly
What happened
-
Mar 15, 2022
The session ended, and the bill died with it.
-
Aug 5, 2021
Sent to the Senate Committee on Health.
-
Aug 5, 2021
Introduced in the Senate.
See the official record, word for word Hide the official record
- Aug 5, 2021 · Senate
Introduced by Senators Agard, Erpenbach, Johnson, Ringhand, Carpenter, Larson, Pfaff, Wirch and Smith; cosponsored by Representatives Conley, Hebl, Snodgrass, Andraca, Neubauer, Shelton, Stubbs, Pope, Sinicki, Vruwink, Spreitzer, Vining, Cabral-Guevara, Bowen, S. Rodriguez and Shankland
- Aug 5, 2021 · Senate
Read first time and referred to Committee on Health
- Mar 15, 2022 · Senate
Failed to pass pursuant to Senate Joint Resolution 1
Terms on this page
Committee
A small group of lawmakers that looks at a bill first. Most bills never leave committee.
Public hearing
A meeting where anyone can speak to a committee about a bill, or send written comments.
Senate Joint Resolution 1
The session's calendar. Any bill not passed by its last voting day dies.
Official term: Failed to pass pursuant to SJR 1. More in the glossary
Legislative Reference Bureau
The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.
Official term: LRB analysis. More in the glossary
Author
A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.
Official term: Author, coauthor. More in the glossary
Signed on in support
Lawmakers who back a bill without being one of its authors, often from the other chamber.
Official term: Cosponsor. More in the glossary
From the Wisconsin Legislature's official record, checked Sep 15, 2026. See the source
Committee
A small group of lawmakers that looks at a bill first. Most bills never leave committee.
Public hearing
A meeting where anyone can speak to a committee about a bill, or send written comments.
Senate Joint Resolution 1
The session's calendar. Any bill not passed by its last voting day dies.
Official term: Failed to pass pursuant to SJR 1
Legislative Reference Bureau
The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.
Official term: LRB analysis
Signed on in support
Lawmakers who back a bill without being one of its authors, often from the other chamber.
Official term: Cosponsor